Showing results (71-80 of 2,991) with videos related to
Sort By:
Pageof 300
Seminars in Thrombosis and Hemostasis|March 18, 2003
Gene transfer as an approach to treating hemophiliaKatherine A HighSeminars in Thrombosis and Hemostasis|January 22, 2003
Increased expression of plasminogen activator inhibitor-1 with fibrin deposition in a murine model of aging, "Klotho" mouseKyosuke Takeshita, Koji Yamamoto, Masafumi Ito, et al.Seminars in Thrombosis and Hemostasis|November 7, 2002
Hirudin as alternative anticoagulant--a historical reviewFritz MarkwardtSeminars in Thrombosis and Hemostasis|November 7, 2002
Hirudin in heparin-induced thrombocytopeniaNorbert Lubenow, Andreas GreinacherSeminars in Thrombosis and Hemostasis|September 24, 2002
Active conformations of glycosaminoglycans. NMR determination of the conformation of heparin sequences complexed with antithrombin and fibroblast growth factors in solutionMilos Hricovíni, Marco Guerrini, Antonella Bisio, et al.Seminars in Thrombosis and Hemostasis|September 24, 2002
Low-molecular-weight heparin and dermatan sulfate end group-labeled with tyramine and fluorescein. Biochemical and biological characterization of the fluorescent-labeled heparin derivativeJob Harenberg, Benito Casu, Marco Guerrini, et al.Seminars in Thrombosis and Hemostasis|July 5, 2002
The use of recombinant factor VIII products in previously treated patients with hemophilia A: pharmacokinetics, efficacy, safety, and inhibitor developmentChristine LeeSeminars in Thrombosis and Hemostasis|July 5, 2002
Immunology of factor VIII inhibitorsJean-Marie R Saint-RemySeminars in Thrombosis and Hemostasis|July 5, 2002
First and next generation native rFVIII in the treatment of hemophilia A. What has been achieved? Can patients be switched safely?Tobias M SuiterPageof 300